IL17A and allergic asthma: Furthermore, local application of polyinosinic:polycytidylic acid (polyIC) to mice with OVA-induced experimental allergic asthma led to infiltration of IL-17A, producing natural killer (NK) cells and expression of IL-17C, which mediate exacerbation of airway inflammation, mucus hyperproduction, and AHR [75,76].